AQR Capital Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $268K | Sell |
29,063
-78
| -0.3% | -$719 | ﹤0.01% | 2923 |
|
|
2025
Q1 | $250K | Sell |
29,141
-19,174
| -40% | -$165K | ﹤0.01% | 2773 |
|
|
2024
Q4 | $519K | Sell |
48,315
-88,329
| -65% | -$949K | ﹤0.01% | 2235 |
|
|
2024
Q3 | $776K | Buy |
136,644
+91,425
| +202% | +$519K | ﹤0.01% | 1970 |
|
|
2024
Q2 | $191K | Buy |
45,219
+26,821
| +146% | +$113K | ﹤0.01% | 2433 |
|
|
2024
Q1 | $93.6K | Sell |
18,398
-203
| -1% | -$1.03K | ﹤0.01% | 2344 |
|
|
2023
Q4 | $173K | Buy |
18,601
+1,809
| +11% | +$16.8K | ﹤0.01% | 2234 |
|
|
2023
Q3 | $110K | Buy |
16,792
+3,459
| +26% | +$22.7K | ﹤0.01% | 2219 |
|
|
2023
Q2 | $108K | Buy |
13,333
+892
| +7% | +$7.25K | ﹤0.01% | 2140 |
|
|
2023
Q1 | $107K | Sell |
12,441
-12,937
| -51% | -$111K | ﹤0.01% | 2113 |
|
|
2022
Q4 | $235K | Sell |
25,378
-393
| -2% | -$3.64K | ﹤0.01% | 2039 |
|
|
2022
Q3 | $266K | Buy |
25,771
+1,469
| +6% | +$15.2K | ﹤0.01% | 1975 |
|
|
2022
Q2 | $243K | Sell |
24,302
-4,117
| -14% | -$41.2K | ﹤0.01% | 1930 |
|
|
2022
Q1 | $350K | Sell |
28,419
-8,061
| -22% | -$99.3K | ﹤0.01% | 1930 |
|
|
2021
Q4 | $633K | Buy |
36,480
+5,854
| +19% | +$102K | ﹤0.01% | 1751 |
|
|
2021
Q3 | $550K | Buy |
30,626
+1,431
| +5% | +$25.7K | ﹤0.01% | 1827 |
|
|
2021
Q2 | $667K | Buy |
29,195
+776
| +3% | +$17.7K | ﹤0.01% | 1775 |
|
|
2021
Q1 | $425K | Sell |
28,419
-11,213
| -28% | -$168K | ﹤0.01% | 1897 |
|
|
2020
Q4 | $214K | Buy |
39,632
+1,694
| +4% | +$9.15K | ﹤0.01% | 2075 |
|
|
2020
Q3 | $173K | Buy |
37,938
+1,923
| +5% | +$8.77K | ﹤0.01% | 2078 |
|
|
2020
Q2 | $177K | Buy |
36,015
+15,456
| +75% | +$76K | ﹤0.01% | 2008 |
|
|
2020
Q1 | $65K | Buy |
+20,559
| New | +$65K | ﹤0.01% | 1991 |
|